Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Eileen Reilly"'
Autor:
L. Sun, Eileen Reilly, Syed Rizvi, Carol Oerth, Laura McBride, Constantine S. Mitsiades, Judy Chiao, Kathleen Colson, Ivy Fearen, Justin L. Ricker, Paul G. Richardson, Kenneth C. Anderson, Barbara Atkins, David Siegel
Publikováno v:
Leukemialymphoma. 49(3)
A Phase I trial (NCT00109109) of oral vorinostat 200, 250 or 300 mg twice daily for 5 days/week/4-week cycle or 200, 300, or 400 mg twice daily for 14 days/3-week cycle until progressive disease or intolerable toxicity was conducted. Patients with me
Autor:
Ivy Fearen, Kenneth C. Anderson, Paul G. Richardson, David S. Siegel, Syed Rizvi, L. Sun, Barbara Atkins, Laura McBride, Carol Oerth, Eileen Reilly, Constantine S. Mitsiades, Judy Chiao, Kathleen Colson, Justin L. Ricker
Publikováno v:
Blood. 110:1179-1179
Background: The histone deacetylase inhibitor vorinostat was approved by the United States FDA in October 2006 for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent dise